Cargando…
p53-Dependent Activation of microRNA-34a in Response to Etoposide-Induced DNA Damage in Osteosarcoma Cell Lines Not Impaired by Dominant Negative p53 Expression
Osteosarcoma (OS) is the most common primary malignant bone tumor and prevalently occurs in the second decade of life. Etoposide, a chemotherapeutic agent used in combined treatments of recurrent human OS, belongs to the topoisomerase inhibitor family and causes DNA breakage. In this study we evalua...
Autores principales: | Novello, Chiara, Pazzaglia, Laura, Conti, Amalia, Quattrini, Irene, Pollino, Serena, Perego, Paola, Picci, Piero, Benassi, Maria Serena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4260944/ https://www.ncbi.nlm.nih.gov/pubmed/25490093 http://dx.doi.org/10.1371/journal.pone.0114757 |
Ejemplares similares
-
miR-106B-25 Cluster expression: a comparative human and canine osteosarcoma study
por: Leonardi, Leonardo, et al.
Publicado: (2020) -
CXCR4 in human osteosarcoma malignant progression. The response of osteosarcoma cell lines to the fully human CXCR4 antibody MDX1338
por: Pollino, Serena, et al.
Publicado: (2019) -
Prognostic and predictive role of CXCR4, IGF-1R and Ezrin expression in localized synovial sarcoma: is chemotaxis important to tumor response?
por: Palmerini, Emanuela, et al.
Publicado: (2015) -
Etoposide induces cell death via mitochondrial-dependent actions of p53
por: Jamil, Sarwat, et al.
Publicado: (2015) -
p53 tetramerization: at the center of the dominant-negative effect of mutant p53
por: Gencel-Augusto, Jovanka, et al.
Publicado: (2020)